Press Releases

FluoGuide Reports Q1 2024 Results for Targeted Urology Solutions

Arsenal May 30, 2024

AI Boosts Biopharma Sustainability, but at What Environmental Cost?

Arsenal May 29, 2024

Streamlining Clinical Trials: Strategies for Efficiency in Modern Medical Research

Arsenal May 28, 2024

FluoGuide Picks Laser for Precision Cancer Therapy with FG001

Arsenal May 27, 2024

Felzartamab Shows Promise for Late Antibody-Mediated Kidney Transplant Rejection

Arsenal May 27, 2024

Atrogi Reveals Breakthrough in Treating Obesity and Metabolic Disorders

Arsenal May 24, 2024

Nona Biosciences Licenses AstraZeneca Antibody for Targeted Cancer Therapies

Arsenal May 23, 2024

Top 10 Biopharma CEO Pay Gaps: Execs Earn 100x Median Employee

Arsenal May 22, 2024

Valneva Names Dr. Hanneke Schuitemaker as New Chief Scientific Officer

Arsenal May 21, 2024

Dyne Reveals New ACHIEVE and DELIVER Clinical Trial Data

Arsenal May 20, 2024

Erasca Prices 86.5M Share Offering at $1.85 for RAS/MAPK Cancer Therapies

Arsenal May 17, 2024

Spago Nanomedical’s 2023 Annual Report Now Available Online

Arsenal May 16, 2024

Biopharma’s AI Revolution: From Drug Design to Safety Monitoring

Arsenal May 15, 2024

Allozymes Secures $15M Series A to Revolutionize Industries with Enzymes

Arsenal May 14, 2024

Organovo Announces $5.25M Public Offering of Common Stock and Warrants

Arsenal May 9, 2024

Colossal’s Gene Tech Could Save Australia’s Endangered Northern Quoll

Arsenal May 8, 2024

HORA-PDE6b Gene Therapy Shows Promise for Retinitis Pigmentosa at 24 Months

Arsenal May 7, 2024

Improved AAV Gene Therapies: Precision, Targeting, and Common Diseases

Arsenal May 6, 2024

AAVantgarde Unveils Innovative Clinical Trial Design for Usher 1B Gene Therapy

Arsenal May 3, 2024

Medigene Unveils Enhanced TCR-T Cell Function with Costimulatory Switch Protein

Arsenal May 2, 2024

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

UK Government’s Controversial Move: Doubling Pharmaceutical Rebates Could Impact NHS Funding and Drug Prices

First Timers Club: Biopharma Launches in 2025 and 2026

Revolutionizing Parkinson’s Treatment: MeiraGTx Partners with AI Startup Hologen to Enhance Gene Therapy Solutions

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA